A Phase 1, Open-label, Drug Interaction Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants with Moderate to Severe Crohn's Disease

Administered By

Awarded By

Contributors

Start/End

  • February 12, 2018 - April 10, 2022